On one hand, there's the promise of a groundbreaking technology. On the other hand, huge risk. Which hand wins? (Date:09/16/2018 12:59) Read full article >>

Related News about "Is CRISPR Therapeutics AG a Buy?" news from other sites: (news similarity rate is shown on left.)

A CRISPR Approach for Accurately Classifying BRCA1 Variants CRISPR editing technology has been used to study mutations in the BRCA1 gene and provides function scores that determine clinical risk. Medscape Medical News.. >>
Moderna Therapeutics, a biotech unicorn valued at more than $7.5 billion, could be gearing up for an IPO as early as this winter Biotech unicorn Moderna Therapeutics, which is valued at more than $7.5 billion, may file for an initial public offering as early as this winter, according to STAT news.  The company has r.. BusinessInsider >>
U.S. appeals court upholds MIT, Harvard patents on CRISPR gene editing A U.S. appeals court on Monday allowed a research center affiliated with the Massachusetts Institute of Technology and Harvard University to keep patents potentially worth billions of dollars on a gro.. >>
HOW DOES CRISPR DNA EDITING WORK?  The CRISPR gene editing technique is being used an increasing amount in health research because it can change the building blocks of the body... >>
Here's Why INSYS Therapeutics, Inc. Jumped a Whopping 40.3% in August A settlement with the U.S. Department of Justice started August off on a good foot, but the month was capped off with a short squeeze... >>